DSM signs up for Chiral Quest technology

- Last updated on GMT

Related tags: Chiral quest, Chemical compound, Enantiomer

Chiral Quest has forged an alliance with DSM to accelerate the
take-up of its catalysis products, used in the synthesis of
chemicals and pharmaceuticals.

Under the terms of the agreement, DSM has taken out a license to a range of catalysts and technologies for the synthesis of intermediates used in the life sciences industry, and will be able to include them in the range of services it offers to customers for its contract manufacturing services. In addition, DSM will use the catalysts in its own internal screening programmes.

Chiral Quest's catalysts are mostly used for the synthesis of single-enantiomer (chiral) molecules, which are growing in importance in the pharmaceutical industry.

Organic compounds tend to exist in two mirror image forms or enantiomers. Whether a compound is left-handed or right-handed plays a role in many aspects of modern science, but it has a major impact in the pharmaceutical industry. Today the majority of new drugs being introduced are made in one chiral form, and this has led to an increased market for tools used in their production.

Dr Ronald Gebhard, R&D director of DSM Pharma Chemicals, said "the Chiral Quest products are complementary to our in-house libraries of ligands and will allow us to broaden our products offerings to our customers in the life sciences industry."

Meantime, Chiral Quest has signed a distribution agreement with US chemicals company Sigma-Aldrich, which will act as a distributor for its Binaphane, C3-TunePhos, TangPhos and Binapine ligands.

Related news

Show more

Related products

show more

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

The Effect of Tamping Force on Bi-Layer Tablets

The Effect of Tamping Force on Bi-Layer Tablets

JRS PHARMA | 15-Aug-2020 | Technical / White Paper

Formulation of bi-layer or multi-layer tablets enables the combination of two or more drugs that may be incompatible or maybe intended for delivery at...

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Related suppliers

Follow us

Products

View more

Webinars